Company Monitoring Page for Novartis

latest headlines for company on cafepharma

3 Breast Cancer Drugs With Big Potential
Motley Fool
Thu, 04/10/14 - 10:37 am
Tags:
breast cancer, Pfizer, Novartis, Eli Lilly, LEE011, LY2835219, palbociclib, CDK 4/6 inhibitors
Novartis names two new leaders to growth drivers Alcon, Sandoz
Fierce Pharma
Wed, 04/9/14 - 09:43 pm
Tags:
Alcon, Sandoz, Novartis
Novartis, NEA join $188M gamble on China biotech fund
Fierce Biotech
Wed, 04/9/14 - 11:51 am
Tags:
China, NEA, Novartis
Tale Of Two Heart Drugs Show Challenges And Rewards In R&D
Forbes
Wed, 04/9/14 - 08:51 am
Tags:
LCZ696, Novartis, heart failure, darapladib, R&D, heart disease, GSK
Why Big Pharma May Not Be Cashing in on Medical Marijuana
Wall St Cheat Sheet
Tue, 04/8/14 - 10:47 am
Tags:
Medical Marijuana, Bayer, Novartis, GW Pharma
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
Forbes
Mon, 04/7/14 - 12:53 pm
Tags:
FDA, Novartis, Bexsero, vaccines, breakthrough therapies, meningitis B
Novartis AG Seeks to Pump More Value into its R&D
Motley Fool
Mon, 04/7/14 - 10:25 am
Tags:
Novartis, R&D
Pfizer Breast Cancer Drug Helps Revive Discarded Strategy
Bloomberg
Mon, 04/7/14 - 08:46 am
Tags:
Pfizer, Eli Lilly, palbociclib, Novartis, bemaciclib, breast cancer, CDK 4/6 inhibitors
Pharma giants jostle for the cancer R&D spotlight at AACR
Fierce Biotech
Fri, 04/4/14 - 09:39 am
Tags:
R&D, AACR, Novartis, Pfizer
Big Pharma dusts itself off in China scandal, but crackdown isn't over
Fierce Pharma
Fri, 04/4/14 - 09:36 am
Tags:
China, GSK, Novartis
Novartis replaces senior management at Japanese unit amid leukaemia drug study probe
First Word Pharma
Thu, 04/3/14 - 09:34 am
Tags:
Novartis, Japan
Novartis Japan staffers shredded and deleted to cover trial misconduct, panel finds
Fierce Pharma
Thu, 04/3/14 - 09:24 am
Tags:
Novartis, Japan, clinical trial data
A New Novartis Heart Failure Drug Might Be A Blockbuster
Forbes
Tue, 04/1/14 - 01:07 pm
Tags:
Novartis, heart failure, LCZ696
Just a Standard “Breakthrough”: FDA’s Unusual Designations for Novartis’ Serelaxin
Pharma and MedTech Business Intelligence
Tue, 04/1/14 - 08:12 am
Tags:
FDA, Novartis, serelaxin
Novartis halts Phase III study of heart failure drug LCZ696 early on positive results
First Word Pharma
Mon, 03/31/14 - 09:59 am
Tags:
LCZ696, Novartis, heart failure
FDA And Meningitis B: Picking Winners And Losers
Forbes
Fri, 03/28/14 - 10:19 am
Tags:
meningitis B, FDA, Novartis, vaccines, Bexsero, Pfizer, bivalent rLP2086
FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug
Forbes
Thu, 03/27/14 - 04:58 pm
Tags:
FDA, Novartis, serelaxin, acute heart failure, advisory panels, Reasanz
FDA staff review recommends against Novartis heart failure drug
Yahoo/Reuters
Tue, 03/25/14 - 08:36 am
Tags:
FDA, Novartis, acute heart failure, serelaxin, advisory panels, S
Quality woes point to generic drugs shake-out: Novartis
Yahoo/Reuters
Mon, 03/24/14 - 06:31 pm
Tags:
Novartis, quality, generics, Joe Jimenez
Novartis chairman stresses need for R&D investment
MarketWatch
Sat, 03/22/14 - 01:19 pm
Tags:
Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.